BPN-15606

BPN-15606 Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com
Company Name: Suzhou Chenrui Biotechnology Co. LTD  
Tel: 17625585511
Email: 1580084073@qq.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com

BPN-15606 manufacturers

  • BPN-15606
  • BPN-15606 pictures
  • $4250.00
  • 2026-07-15
  • CAS:1914989-49-3
  • Purity:
  • Supply Ability: 10g
BPN-15606 Basic information
Product Name:BPN-15606
Synonyms:BPN-15606;BPN15606,BPN 15606;3-Pyridazinamine, N-[(1S)-1-(4-fluorophenyl)ethyl]-6-[6-methoxy-5-(4-methyl-1H-imidazol-1-yl)-2-pyridinyl]-4-methyl-
CAS:1914989-49-3
MF:C23H23FN6O
MW:418.47
EINECS:
Product Categories:
Mol File:1914989-49-3.mol
BPN-15606 Structure
BPN-15606 Chemical Properties
Boiling point 620.5±55.0 °C(Predicted)
density 1.27±0.1 g/cm3(Predicted)
pka4.19±0.10(Predicted)
form Solid
color White to yellow
Safety Information
MSDS Information
BPN-15606 Usage And Synthesis
DescriptionBPN-15606 is a highly potent, orally active γ-secretase modulator (GSM). GSM attenuates the production of Aβ42 by SHSY5Y neuroblastoma cells.
UsesBPN-15606 is a highly potent, orally active γ-secretase modulator (GSM), attenuates the production of Aβ42 and Aβ40 by SHSY5Y neuroblastoma cells with IC50 values of 7 nM and 17nM, respectively. BPN-15606 lowers Aβ42 and Aβ40 levels in the central nervous system of rats and mice. BPN-15606 has acceptable PK/PD properties, including bioavailability, half-life, and clearance[1].
in vivo

BPN-15606 (oral administration; 10 mg/kg, 25 mg/kg and 50 mg/kg; 7 days) shows excellent dose-dependent efficacy in both plasma and brain on lowering of Aβ42 and Aβ40 levels in mice[1]. BPN-15606 (oral administration; 5 mg/kg, 25 mg/kg and 50 mg/kg; 9 days) dose-dependently reduces CSF on lowering of Aβ42 and Aβ40 levels in rats[1]. BPN-15606 (oral administration; 25 mg/kg; single dose) shows a robust effect on both brain and plasma Aβ 42 and Aβ40 levels, which begins approximately 30–60 minutes following the single dose administration and lasted for ≥24 hours in C57BL/6 mice[1].

References[1] Wagner SL, et al. Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606. J Pharmacol Exp Ther. 2017 Jul;362(1):31-44. DOI:10.1124/jpet.117.240861
BPN-15606 Preparation Products And Raw materials
Tag:BPN-15606(1914989-49-3) Related Product Information
NA BPN-15606 3-Pyridazinamine, 6-[6-methoxy-5-(4-methyl-1H-imidazol-1-yl)-2-pyridinyl]-N-[(1S)-1-(4-methoxyphenyl)ethyl]-4-methyl- cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid MRK 560 2-(S)-(3,5-Bis(4-(trifluoromethyl)phenyl)phenyl)-4-methylpentanoic acid